GlassScriptPhysician profile
Chad Benjamin Vanasselberg
NPI 1265630826
$1,434.95
in general payments reported to CMS, 2019-2025
20 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $13.55 · 2021: $148 · 2022: $74.24 · 2023: $169 · 2024: $49.15 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $267.70 | 2019-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $191.52 | 2019 | |
| Genzyme Corporation | $143.26 | 2019-2025 | |
| Inari Medical, INC. | $138.44 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ethicon INC. | $133.16 | 2021 | |
| Genentech USA, INC. | $126.31 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.85 | 2019 | |
| Sunovion Pharmaceuticals INC. | $64.74 | 2019 | |
| Intuitive Surgical, INC. | $47.08 | 2022 | |
| Circassia INC. | $30.73 | 2019 | |
| Insmed, INC. | $30.64 | 2019 | |
| Mylan Specialty L.P. | $30.40 | 2019 | |
| Grifols USA, LLC | $27.83 | 2019 | |
| Gilead Sciences, INC. | $26.54 | 2019 | |
| United Therapeutics Corporation | $21.53 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $16.75 | 2019 | |
| Advanced Respiratory, INC | $15.90 | 2019 | |
| Philips North America LLC | $13.55 | 2020 | |
| Allergan, INC. | $11.72 | 2019 | |
| Merck Sharp & Dohme LLC | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Vanasselberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.